Belamy B. Cheung

Cancer Institute of New South Wales — Australia

Medicine · Health Sciences

33h-index3.5kcitations191works2.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(123), Protein Degradation and Inhibitors(33), Cancer, Hypoxia, and Metabolism(29), interferon and immune responses(23), Ubiquitin and proteasome pathways(21)

Publications191 total

PA2G4 Functions as a Cofactor for MYC Family Oncoproteins in MYC-Driven Malignancies
Cells·2025Open Access
Abstract 6863: Development of MYCN/MYC inhibitors
Cancer Research·2025
Abstract 2613: The role of the RNA methyltransferase RNAMT1 as a tumorigenic driver and therapeutic target in neuroblastoma
Cancer Research·2025
Abstract 2608: The super enhancer-driven long noncoding RNA lncNB promotes neuroblastoma tumorigenesis by interacting with MSI2 protein and is targetable by small molecule compounds
Cancer Research·2025
Abstract 1680: Therapeutically targeting genes and pathways activated by high-fat diet in high-risk neuroblastoma
Cancer Research·2025
The Super Enhancer‐Driven Long Noncoding RNA PRKCQ‐AS1 Promotes Neuroblastoma Tumorigenesis by Interacting With MSI2 Protein and Is Targetable by Small Molecule Compounds
Advanced Science·2025· 5 citedOpen Access
Combined inhibition of histone methyltransferases <scp>EZH2</scp> and <scp>DOT1L</scp> is an effective therapy for neuroblastoma
Cancer Medicine·2024· 5 citedOpen Access
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
Communications Biology·2024· 1 citedOpen Access
Loss of the stress sensor GADD45A promotes stem cell activity and ferroptosis resistance in LGR4/HOXA9-dependent AML
Blood·2024· 19 citedOpen Access
Abstract 1080: Using genome-wide CRISPR screening to develop novel combination therapies for high-risk Ewing’s sarcoma
Cancer Research·2024
Abstract 4599: A novel small molecule inhibitor targeting MYC oncogenic signaling as an enhancer of HDAC inhibitors for the treatment of high-risk medulloblastoma
Cancer Research·2024· 1 cited
MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression
Oncogene·2023· 8 citedOpen Access
Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma
International Journal of Molecular Sciences·2023Open Access
Supplementary Figure S6 G-K from Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
2023Open Access
Supplementary Figure S4 from Targeted Therapy of &lt;i&gt;TERT&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
2023Open Access
Supplementary Figure S7 from Targeted Therapy of &lt;i&gt;TERT&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
2023Open Access
Supplementary Figure S2 from Targeted Therapy of &lt;i&gt;TERT&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
2023Open Access
Supplementary Materials &amp; Methods from Targeted Therapy of &lt;i&gt;TERT&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
2023Open Access
Supplementary Figure S5 from Targeted Therapy of &lt;i&gt;TERT&lt;/i&gt;-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy
2023Open Access
Data from Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Glenn M. Marshall(45), Michelle Haber(31), Murray D. Norris(31), Tao Liu(23), Daniel R. Carter(19), Jessica Koach(13), Bing Liu(12), Owen Tan(11), Jessica L. Bell(10), Maria Kavallaris(9), Chelsea Mayoh(8), Katleen De Preter(8), Anneleen Beckers(8), Pei Y. Liu(8), Andrew E. Tee(8), Xu Dong Zhang(7), Matthias Fischer(7), Eric Sekyere(7), Wayne Thomas(7), Stewart A. Smith(7)